// June 26, 2023
Complex generics: Are global regulators addressing the needs?
The development of generic versions of innovator medicines is a global public health need.
The development of generic versions of innovator medicines is a global public health need.
The issue of addressing potential nitrosamine impurities in medicines has been the focus at event
Continued global cooperation to strengthen supply chain resilience and assure medicines quality w
USP has launched the newest tool in our suite of solutions to address the evolving nitrosamines c